Almirall stock trades at EUR 10.56 as EBITDA rises 23.7 percent

Published on 09/25/2026 at 12:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Almirall stock is 24.46 percent below its 52-week high on September 25, 2026. H1 net sales reached EUR 602.7 million, with net income 49.4 percent above the prior year.

Dermatologe untersucht Patientenrücken mit Dermatoskop vor Barcelona-Skyline — Almirall S.A. (ES0157097017) zeigt Dermatologie-Praxis mit Hautuntersuchung und unbeschrifteten Cremetuben in Barcelona, Illustration mit AI erstellt.

Almirall (ISIN ES0157097017) stock was trading at EUR 10.56 on BME on September 25, 2026, up 0.57 percent from the prior close. The price remained 24.46 percent below its 52-week high of EUR 13.98, while first-half results showed faster earnings growth than sales growth.

EBITDA growth outpaces sales

In the first half of 2026, net sales reached EUR 602.7 million, an increase of 7.5 percent from EUR 560.5 million in the first half of 2025, according to Almirall in its July 24, 2026 release.

EBITDA rose 23.7 percent to EUR 150.7 million from EUR 121.8 million, lifting the EBITDA margin to 25.0 percent from 21.7 percent. That 3.3 percentage-point margin improvement gives the results a stronger operating profile than the top-line growth alone suggests.

Dermatology supplies the growth

European dermatology net sales increased 18.1 percent year over year to EUR 341.9 million in the same period. Ebglyss sales reached EUR 84.5 million, up 88.2 percent, while Ilumetri generated EUR 125.2 million, an increase of 10.5 percent, according to Almirall.

Net income reached EUR 39.6 million, compared with EUR 26.5 million a year earlier, representing growth of 49.4 percent. The result puts reported profit growth ahead of both revenue and EBITDA growth for the first half.

Guidance points to continued expansion

Almirall reiterated 2026 guidance for net sales growth of 9 percent to 12 percent and EBITDA of EUR 270 million to EUR 290 million. The company also disclosed that its next reporting date is November 9, 2026, for the first nine months of 2026, on its investor page.

Almirall stock stays below yearly high

Almirall stock was trading at EUR 10.56 on BME on September 25, 2026. The session volume was 155,590 shares, market capitalization was EUR 2,299,725,120, and the 52-week range stood at EUR 10.02 to EUR 13.98.